Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-30 Exercise | 2024-04-02 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 1,856,163 | $6.4 | 5,309,683 (Direct) | View |
| 2024-03-30 Exercise | 2024-04-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 729,081 | $0 | 5,309,683 (Direct) | View |
| 2024-03-30 Tax Withholding | 2024-04-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 366,211 | $10.54 | 5,309,683 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 28,411 | $11.5 | 8,109,865 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 159,100 | $6.4 | 8,109,865 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 71,365 | $0 | 8,109,865 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 28,411 | $11.5 | 8,226,011 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 53,033 | $6.4 | 8,226,011 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 27,790 | $0 | 8,226,011 (Direct) | View |
| 2023-08-27 Exercise | 2023-08-29 9:31 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 53,033 | $6.4 | 6,915,954 (Direct) | View |
| 2023-08-27 Exercise | 2023-08-29 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 22,565 | $0 | 6,915,954 (Direct) | View |
| 2023-07-27 Exercise | 2023-07-31 9:35 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 106,067 | $6.4 | 6,946,422 (Direct) | View |
| 2023-07-27 Exercise | 2023-07-31 9:35 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 43,212 | $0 | 6,946,422 (Direct) | View |
| 2023-05-27 Exercise | 2023-05-31 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks | 318,199 | $6.4 | 7,009,277 (Direct) | View |
| 2023-05-27 Exercise | 2023-05-31 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks | 99,458 | $0 | 7,009,277 (Direct) | View |
| 2022-04-20 Option Award | 2022-04-22 7:31 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks | 16,523,184 | $0 | 16,523,184 (Direct) | View |
Ownership | 2021-10-01 5:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres &Chief Investment Officer | 0 | $0 | 18,128,339 (Direct) | View |